Homepage
Medication Guide
Indications for Ongentys (Opicapone)
Ongentys (Opicapone) is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor, providing an important adjunctive treatment option for managing "off" episodes in patients w...
502
Tuesday, September 23rd, 2025, 14:49
Precautions for Doptelet (Avatrombopag) Administration
Doptelet (Avatrombopag) is an oral thrombopoietin receptor agonist, primarily used for the treatment of thrombocytopenia in adult patients with chronic liver disease prior to a scheduled surgery. As a...
503
Tuesday, September 23rd, 2025, 14:46
How to Use Doptelet (Avatrombopag)
Doptelet (Avatrombopag) is an oral thrombopoietin receptor agonist, primarily used for the treatment of thrombocytopenia in adult patients with chronic liver disease.How to Use Doptelet (Avatrombopag)...
502
Tuesday, September 23rd, 2025, 14:43
Indications for Doptelet (Avatrombopag)
As an oral thrombopoietin receptor agonist, Doptelet (Avatrombopag) provides an innovative solution for the preoperative management of patients with thrombocytopenia associated with chronic liver dise...
504
Tuesday, September 23rd, 2025, 14:41
What Are the Side Effects of Capivasertib?
Capivasertib, when used in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative,...
508
Tuesday, September 23rd, 2025, 14:04
How Effective is Capivasertib in Treatment?
As a novel AKT kinase inhibitor, Capivasertib provides a new treatment option for patients with specific types of advanced breast cancer.How Effective is Capivasertib in Treatment?Pharmacological Acti...
504
Tuesday, September 23rd, 2025, 14:00
Precautions for Capivasertib Administration
Capivasertib is a kinase inhibitor that received its first approval for marketing in the United States in 2023. When used in combination with fulvestrant, this medication is indicated for the treatmen...
503
Tuesday, September 23rd, 2025, 13:56
Indications for Capivasertib
Capivasertib is a novel kinase inhibitor developed by AstraZeneca. It first received approval from the U.S. Food and Drug Administration (FDA) for marketing in 2023, providing a new treatment option f...
503
Tuesday, September 23rd, 2025, 13:51
Precautions for Biktarvy Administration
Biktarvy is a three-in-one fixed-dose combination antiretroviral medication containing bictegravir (BIC), emtricitabine (FTC), and tenofovir alafenamide (TAF). It is used for the treatment of HIV-1 in...
506
Tuesday, September 23rd, 2025, 13:47
Indications for Biktarvy
As a three-in-one fixed-dose combination anti-HIV-1 medication, Biktarvy consists of bictegravir, emtricitabine, and tenofovir alafenamide. Developed by Gilead Sciences, it first received approval fro...
504
Tuesday, September 23rd, 2025, 13:40
86 / 186
1852 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved